Privia Health Group, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $2.1B | $1.7B | $1.7B | $1.4B | $966.2M |
| Operating expenses | $2.1B | $1.7B | $1.6B | $1.4B | $1.2B |
| Operating income | $34.2M | $17.0M | $20.6M | -$19.1M | -$217.4M |
| Interest expense | — | — | — | $500,000 | $1.1M |
| Pretax income | $43.9M | $27.9M | $29.0M | -$18.6M | -$218.5M |
| Income tax expense | $14.2M | $10.8M | $8.0M | -$6.5M | -$27.9M |
| Net income | $22.9M | $14.4M | $23.1M | -$8.6M | -$188.2M |
| Balance Sheet | |||||
| Cash and equivalents | $479.7M | $491.1M | $389.5M | $348.0M | $320.6M |
| Current assets | $911.0M | $834.8M | $700.8M | $552.0M | $446.7M |
| Total assets | $1.4B | $1.1B | $999.9M | $792.8M | $686.4M |
| Current liabilities | $568.5M | $449.1M | $387.0M | $264.3M | $190.5M |
| Total liabilities | $578.4M | $452.3M | $392.5M | $273.8M | $236.2M |
| Total debt | — | — | — | — | $33.2M |
| Stockholders' equity | $737.2M | $635.2M | $561.4M | $499.1M | $426.9M |
| Cash Flow Statement | |||||
| Cash from operations | $163.4M | $109.3M | $80.8M | $47.2M | $55.1M |
| Depreciation and amortization | $9.9M | $7.3M | $6.5M | $4.6M | $2.5M |
| Stock-based compensation | $71.1M | $56.7M | $37.1M | $67.4M | $253.5M |
| Capital expenditure | — | — | $113,000 | $104,000 | $547,000 |
| Free cash flow | — | — | $80.7M | $47.1M | $54.5M |
| Impairments | — | — | — | $0 | $0 |
Shares outstanding 126.0M · Free float 13.5%
Annual filing data through FY ended December 31, 2025; float as of July 15, 2026.